Decreased levels of full-length stathmin-2 mRNA were significantly associated with TDP-43 pathology and detected in TDP-43-associated sporadic ALS, C9 ALS, FTD and Alzheimer’s disease [188,189,190]. The gene discussed is STMN2; the disease is frontotemporal dementia.